Transcript Plans for 2009_2011 Atlas - Alberta Diabetes Surveillance System

Alberta Diabetes Atlas
2009 and 2011
ADSS SC Terms of Reference
1.
Advise on Table of Contents and Working
Groups for the Alberta Diabetes Atlas
2.
Advise on format and functionality of ADSS website
Advise on communication strategy for ADSS
When feasible, act as a contributor to relevant
sections/chapters of the Atlas
Advise on formulation of evaluation plan for ADSS
3.
4.
5.
2009 Atlas Table of Contents 2009
Chapter 1: Background and Methods
Chapter 2: Epidemiological Trends
Trends over time, across age and by region
Chapter 3: Diabetes and HC Utilization
Physician Visits, ER, Hospitalization
Cost component: drug costs/system and patient
costs for years 65+ (Blue Cross)
2009 Atlas Table of Contents 2009
Chapter 4: Diabetes and Cardiovascular Disease
Acute Coronary Syndrome
(Acute MI, unstable angina, PCI and CABG)
 Heart Failure
 Stroke



Michael Hill, neurologist UC
Hypertension (new PHAC/CCDSS case def’n)

Hude Quan
2009 Atlas Table of Contents 2009
Chapter 5: Diabetes and Lower Limb Amputation


Add: Diabetes and Foot Disease as a separate
chapter?
Brent Haverstock- Division of Podiatric Surgery, UC
Chapter 6: Diabetes and Kidney Disease
 Dialysis and Transplantation
Chapter 7: Diabetes and Eye Disease
 Retinal photocoagulation, Vitrectomy, Glaucoma and
Cataract Surgery
2009 Atlas Table of Contents 2009
Chapter 8: Diabetes and Mental Health
 Affective disorders
 Anxiety disorders
 Non-organic and organic psychoses
 Substance Abuse disorders
 Eating disorders

Scott Patten- Psychiatrist in Calgary
Chapter 9: Diabetes and First Nations people
2009 Atlas Table of Contents 2009
Chapter 10: Diabetes in the Under 20 Year Olds
 Same case definition as adult population
 Require information about case ascertainment (hospital
vs. physician)
Chapter 11: Diabetes and Pregnancy
 FOMD Team (Padma Kaul, Eddie Ryan, Connie Chick, JAJ)


PHAC/CCDSS def’n
Could consider different approaches.
2009 Atlas Working Groups
Chapter 1: Background and Methods
Chapter 2: Epidemiological Trends
Jeff Johnson and Stephanie Vermeulen
Chapter 3: Diabetes and HC Utilization
Jeff Johnson, Doreen Rabi, Alun Edwards, Stephanie
Vermeulen
2009 Atlas Working Groups
Chapter 4: Diabetes and Cardiovascular Disease

Acute Coronary Syndrome
Michelle Graham, Colleen Norris, Sumit Majumdar, Jeff Johnson

Heart Failure
Finlay McAlister, Dean Eurich

Stroke
Scot Simpson, ?? Michael Hill

Hypertension
??Hude Quan, Larry Svenson
2009 Atlas Working Groups
Chapter 5: Diabetes and Lower Limb Amputations
(??and Foot Disease)

Peter Senior, Sean McMurtry, Ross Tsuyuki, Brent Haverstock
Chapter 6: Diabetes and Kidney Disease

Scott Klarenbach, Marcello Tonelli, Brenda Hemmelgarn, Kailash
Jindal
Chapter 7: Diabetes and Eye Disease

Matthew Tennant, Christopher Rudnisky, Jeff Johnson
2009 Atlas Working Groups
Chapter 8: Diabetes and Mental Health Disorders

Scott Patten, Larry Svenson , Lauren Brown
Chapter 9: Diabetes and First Nations People

Brenda Hemmelgarn, Ellen Toth, Malcolm King, Lynden
Crowshoe, Kelli Ralph-Campbell
Chapter 10: Diabetes in the Under 20 Year Old
Population

Bob Couch, Seth Marks, Daniele Pacaud, Jeff Johnson
Chapter 11: Diabetes and Pregnancy

Padma Kaul, Eddie Ryan, Connie Chick, Jeff Johnson
2009 Atlas Timing
Epi Trends
HC Utilization
X
X
CVD
X
X
Sept
Oct
First Nations
Kidney Disease
LL Amputation
Mental Health
Under 20
Pregnancy
July
Aug
X
Nov
Dec
Jan 09
Feb
March
Sheri Pohar
WG review codes and data elements/presentation plan
ADSS Data analyst run data and create initial draft chapter
WG review & edit draft chapter
2009 Dissemination Strategy

Report – targeted for June 2009
Electronic
Website

Newsletter


 Transition
to electronic distribution
(have fewer paper-copies available)
Atlas Table of Contents 2011
Natural History approach

(in addition or in place of Traditional approach...?)
•
Cohort of incident DM cases ’95 & ’96
•
Total n > 14,000 people
•
Report baseline presence and subsequent development
of comorbidities/complications
•
?Presenting regional variation results?
Other Potential Data Sources

•
•
•
Regional Lab data
AHW/Blue Cross Drug data (>65 years)
Survey data (ABCD)